UIG is leading a consortium of global investors in developing a US$2 B (16 B RMB)medical city, known as Beijing China-US International Medical Center ("BIMC") in Beijing, China. BIMC is a joint-venture funded by domestic and foreign institutional investors, in collaboration with Harvard Medical International, Inc., and first-tier Chinese healthcare institutions. BIMC will be a world-class private healthcare provider, delivering the highest quality, patient focused healthcare to both domestic and international communities in Beijing as well as in the world. The development of BIMC city on a 425-acre land will include an international hospital, medical research institute, medical education center, hotels and business center, as well as residential properties and amenities.